ORUVAIL SR ketoprofen 200mg capsule blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

ketoprofen, Quantity: 200 mg

Available from:

Sanofi-Aventis Australia Pty Ltd

Pharmaceutical form:

Capsule, modified release

Composition:

Excipient Ingredients: colloidal anhydrous silica; Shellac; ethylcellulose; purified talc; sucrose; maize starch; erythrosine; Gelatin; titanium dioxide

Administration route:

Oral

Units in package:

7

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

ORUVAIL is recommended in the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute articular and peri- articular disorders (bursitis, capsulitis, synovitis, tendonitis), cervical spondylitis, low back pain (strain, lumbago, sciatica, fibrositis), painful musculo-skeletal conditions and dysmenorrhoea.

Product summary:

Visual Identification: Capsule with pink base and white cap printed with "ORUVAIL 200"; Container Type: Blister Pack; Container Life Time: 3 Years

Authorization status:

Licence status A

Authorization date:

1997-01-07